
RA Capital Management closes $308M venture capital fund
The firm said the new round increased its private deal capacity to nearly $1 billion and total assets under management to around $2.5 billion.
The firm said the new round increased its private deal capacity to nearly $1 billion and total assets under management to around $2.5 billion.
The company hopes the funding will move it toward the clinic. Active clinical programs of gene therapies in Parkinson's include efforts by Voyager Therapeutics and a university in Japan.